Connect
MJA
MJA

Closing the million patient gap of uncontrolled asthma

Tunn Ren Tay, Michael J Abramson and Mark Hew
Med J Aust 2016; 204 (6): 216-217. || doi: 10.5694/mja15.01141

Australia’s burden of asthma requires structural reform in health care delivery

Asthma control is the principal aim of asthma management. Uncontrolled asthma impairs quality of life, increases exacerbation frequency, heightens risk of death, and is four times more costly to treat than controlled asthma. Therefore, results from a web-based Australian asthma survey are disappointing and disquieting.1

Please login with your free MJA account to view this article in full

  • Tunn Ren Tay1
  • Michael J Abramson1,2
  • Mark Hew1,2

  • 1 The Alfred Hospital, Melbourne, VIC
  • 2 Monash University, Melbourne, VIC

Correspondence: M.Hew@alfred.org.au

Competing interests:

Michael Abramson holds grants from Pfizer and Boehringer-Ingelheim and has received personal fees from AstraZeneca and non-financial support from Boehringer Ingelheim and Sanofi unrelated to the content of this article. Mark Hew undertakes research for AstraZeneca, Sanofi, Novartis and GlaxoSmithKline, and has been supported for educational talks by GlaxoSmithKline and Novartis, for which his employer has been reimbursed.

  • 1. Reddel HK, Sawyer SM, Everett PW, et al. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust 2015; 202: 492-497. <MJA full text>
  • 2. Woolcock A, Rubinfeld A, Seale JP, et al. Asthma management plan, 1989. Med J Aust 1989; 151: 50-53.
  • 3. National Asthma Council Australia. Australian asthma handbook, version 1.1. Melbourne: NACA, 2015. http://www.asthmahandbook.org.au (accessed Aug 2015).
  • 4. National Asthma Council Australia. National asthma strategy 2016–2020 [website]. http://www.nationalasthma.org.au/about-us/national-asthma-strategy (accessed Aug 2015).
  • 5. Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD). Confidential enquiry report. London: RCP, 2014. https://www.rcplondon.ac.uk/file/868/download?token=3wikiuFg (accessed Aug 2015).
  • 6. Ley S, Department of Health. Developing a 21st century electronic health record system [media release]. 9 Oct 2015. http://www.health.gov.au/internet/ministers/publishing.nsf/Content/2FBE985B0A162EE6CA257ED9001CDA21/$File/SL122.pdf (accessed Oct 2015).
  • 7. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356: 2040-2052.
  • 8. Kew KM, Karner C, Mindus SM, Ferrara G. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 2013; 12: CD009019.
  • 9. Hew M, Bhavsar P, Torrego A, et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006; 174: 134-141.
  • 10. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. October 2014 (SIGN 141). London: BTS; Edinburgh: SIGN, 2014. http://www.sign.ac.uk/pdf/SIGN141.pdf (accessed Aug 2015).
  • 11. Gibeon D, Heaney LG, Brightling CE, et al. Dedicated severe asthma services improve healthcare utilisation and quality of life. Chest 2015; 148: 870-876.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.